Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial (Q34225132)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial |
scientific article |
Statements
1 reference
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial (English)
1 reference
Gregg W Stone
1 reference
David E Kandzari
1 reference
Cindy L Grines
1 reference
Alexandra J Lansky
1 reference
Giulio Guagliumi
1 reference
Thomas Stuckey
1 reference
James E Tcheng
1 reference
Mark Turco
1 reference
Mark B Effron
1 reference
CADILLAC Investigators
1 reference
David A Cox
1 reference
Eulogio Garcia
1 reference
John J Griffin
1 reference
Martin Fahy
1 reference
25 August 2003
1 reference
1 reference
108
1 reference
11
1 reference
1316-1323
1 reference
Identifiers
1 reference
1 reference